| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology)
|
Mustea, A.
|
|
2013
|
72 |
5 |
p. 975-983
|
artikel
|
| 2 |
A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)
|
Raez, Luis E.
|
|
2013
|
72 |
5 |
p. 1103-1110
|
artikel
|
| 3 |
A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity
|
Kobrinsky, B.
|
|
2013
|
72 |
5 |
p. 1073-1078
|
artikel
|
| 4 |
A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors
|
Okamoto, Wataru
|
|
2013
|
72 |
5 |
p. 1063-1071
|
artikel
|
| 5 |
A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer
|
Takahara, Naminatsu
|
|
2013
|
72 |
5 |
p. 985-990
|
artikel
|
| 6 |
Calcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteers
|
Tawbi, Hussein A.
|
|
2013
|
72 |
5 |
p. 1143-1147
|
artikel
|
| 7 |
Changes in fPSA level could discriminate tPSA flare-up from tPSA progression in patients with castration-refractory prostate cancer during the initial phase of docetaxel-based chemotherapy
|
Du, Jun
|
|
2013
|
72 |
5 |
p. 1055-1061
|
artikel
|
| 8 |
Circadian variability of pharmacokinetics of cisplatin in patients with non-small-cell lung carcinoma: analysis with the NONMEM program
|
Chen, Rong
|
|
2013
|
72 |
5 |
p. 1111-1123
|
artikel
|
| 9 |
Comparative pharmacokinetics of subcutaneous trastuzumab administered via handheld syringe or proprietary single-use injection device in healthy males
|
Wynne, Chris J.
|
|
2013
|
72 |
5 |
p. 1079-1087
|
artikel
|
| 10 |
DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft
|
Zheng, Mao-fa
|
|
2013
|
72 |
5 |
p. 1031-1041
|
artikel
|
| 11 |
Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells
|
Sun, Zheng
|
|
2013
|
72 |
5 |
p. 965-973
|
artikel
|
| 12 |
Exposure–response analysis of pertuzumab in HER2-positive metastatic breast cancer: absence of effect on QTc prolongation and other ECG parameters
|
Garg, Amit
|
|
2013
|
72 |
5 |
p. 1133-1141
|
artikel
|
| 13 |
Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis
|
Liu, Yu
|
|
2013
|
72 |
5 |
p. 1125-1132
|
artikel
|
| 14 |
FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study
|
Kochi, Mitsugu
|
|
2013
|
72 |
5 |
p. 1097-1102
|
artikel
|
| 15 |
Histones and lung cancer: are the histone deacetylases a promising therapeutic target?
|
Petta, Vasiliki
|
|
2013
|
72 |
5 |
p. 935-952
|
artikel
|
| 16 |
Knockdown of cyclophilin A reverses paclitaxel resistance in human endometrial cancer cells via suppression of MAPK kinase pathways
|
Li, Zhengyu
|
|
2013
|
72 |
5 |
p. 1001-1011
|
artikel
|
| 17 |
Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer
|
Park, Sook Ryun
|
|
2013
|
72 |
5 |
p. 953-964
|
artikel
|
| 18 |
Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528
|
Gadgeel, Shirish M.
|
|
2013
|
72 |
5 |
p. 1089-1096
|
artikel
|
| 19 |
Phase I study of the safety, pharmacokinetics and antitumor activity of famitinib
|
Zhou, Aiping
|
|
2013
|
72 |
5 |
p. 1043-1053
|
artikel
|
| 20 |
Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adults
|
Diestelhorst, Christian
|
|
2013
|
72 |
5 |
p. 991-1000
|
artikel
|
| 21 |
Population pharmacokinetics of dimethylacetamide in children during standard and once-daily IV busulfan administration
|
Trame, Mirjam N.
|
|
2013
|
72 |
5 |
p. 1149-1155
|
artikel
|
| 22 |
Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy
|
Kim, Ji-Won
|
|
2013
|
72 |
5 |
p. 1023-1029
|
artikel
|
| 23 |
Tumour tissue selectivity in the uptake and retention of SN 28049, a new topoisomerase II-directed anticancer agent
|
Lukka, Pradeep B.
|
|
2013
|
72 |
5 |
p. 1013-1022
|
artikel
|
Tijdschrift beschrijving